Pharm
Rimantadine
search
Rimantadine
, Flumadine
See Also
Amantadine
Parkinsonism
Influenza
Indications
Parkinsonism
(off-label)
Unlike
Amantadine
, Rimantadine has not typically been used for
Parkinsonism
Rimantadine could be considered in
Parkinsonism
and
Renal Insufficiency
(in which
Amantadine
is contraindicated)
Amantadine
and Rimantadine share the same dosing protocols (at least for
Influenza
)
Rimantadine has been evaluated in small studies and appears to have similar motor affects as
Amantadine
Evidente (1999) Clin Neuropharmacol 22(1):30-2 +PMID: 10047931 [PubMed]
Indications
Influenza
(Listed for historical reasons only)
Precautions: Do not use for
Influenza
management as of 2011 CDC Guidelines
Due to resistance, these agents are not now routinely used for
Influenza
treatment and prophylaxis (use
Neuraminidase Inhibitor
s)
CDC no longer recommends
Amantadine
or Rimantadine for
Influenza
management
Use
Neuraminidase Inhibitor
s instead
Prior indications for
Influenza
A management (no longer used)
Influenza
Prophylaxis
Given if
Vaccine
contraindicated
Can be given concurrently with
Influenza Vaccine
Covers 2 week period until
Immunity
established
Influenza
A Treatment
Shortens course by 1 day and lessens symptoms
Start within 48 hours to be effective
Influenza
B is not covered by these
Antiviral Agent
s
See Neraminidase Inhibitors:
Oseltamivir
(
Tamiflu
) or
Zanamivir
(
Relenza
)
Contraindications
Seizure Disorder
Mechanism
Antiviral Agent
derived from
Adamantane
, and analog of
Amantadine
Releases
Dopamine
from intact nerve terminals
Weak non-competitive
NMDA
receptor
Antagonist
Dosing
Influenza
(Historical)
Gene
ral
CDC no longer recommends
Amantadine
or Rimantadine for
Influenza
prophylaxis or treatment
Prophylaxis and Treatment dosages are the same
Rimantadine not indicated for treatment under age 14
Dose: 4.4 to 8.8 mg/kg/day divided bid for 5 days
May dose daily, but causes greater
Nausea
and
Vomiting
Age 1-9 years old or weight under 40 kg
Rimantadine 5 mg/kg/day orally divided twice daily (up to 75 mg twice daily )
Age 10 to 64 years old
Rimantadine 100 mg orally twice daily
Age over 65 years old OR eGFR <30 ml/min or severe hepatic insufficiency
Rimantadine 100 mg orally daily
Adverse Effects
See
Amantadine
Safety
Pregnancy Category C
Avoid in
Lactation
Pharmacokinetics
In contrast to
Amantadine
, Rimantadine is NOT contraindicated in
Renal Insufficiency
Rimantadine is extensively metabolized, and less than 15% is excreted unchanged in the urine
Drug Interactions
See
Amantadine
Resources
CDC MMWR - ACIP Guidelines on
Antiviral
s in
Influenza
(2011)
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6001a1.htm
Rimantadine (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49f7d69a-820b-4c75-a31d-b2104c019c12
References
(2021) Med Lett Drugs Ther 63(1618): 25-32
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 46-7
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here